| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |